nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—ABCB1—hematologic cancer	0.243	1	CbGaD
Triflupromazine—BCHE—Triamcinolone—hematologic cancer	0.0879	0.138	CbGbCtD
Triflupromazine—BCHE—Irinotecan—hematologic cancer	0.0666	0.105	CbGbCtD
Triflupromazine—ABCB1—Lenalidomide—hematologic cancer	0.0602	0.0947	CbGbCtD
Triflupromazine—BCHE—Cisplatin—hematologic cancer	0.0543	0.0853	CbGbCtD
Triflupromazine—ABCB1—Daunorubicin—hematologic cancer	0.0353	0.0555	CbGbCtD
Triflupromazine—ABCB1—Alitretinoin—hematologic cancer	0.0346	0.0544	CbGbCtD
Triflupromazine—ABCB1—Imatinib—hematologic cancer	0.0271	0.0425	CbGbCtD
Triflupromazine—ABCB1—Nilotinib—hematologic cancer	0.0246	0.0386	CbGbCtD
Triflupromazine—ABCB1—Vinorelbine—hematologic cancer	0.0244	0.0383	CbGbCtD
Triflupromazine—ABCB1—Dasatinib—hematologic cancer	0.0217	0.0342	CbGbCtD
Triflupromazine—ABCB1—Mitoxantrone—hematologic cancer	0.0215	0.0337	CbGbCtD
Triflupromazine—ABCB1—Betamethasone—hematologic cancer	0.0191	0.0301	CbGbCtD
Triflupromazine—ABCB1—Gemcitabine—hematologic cancer	0.019	0.0298	CbGbCtD
Triflupromazine—ABCB1—Prednisolone—hematologic cancer	0.0189	0.0297	CbGbCtD
Triflupromazine—ABCB1—Prednisone—hematologic cancer	0.0178	0.028	CbGbCtD
Triflupromazine—ABCB1—Irinotecan—hematologic cancer	0.0169	0.0266	CbGbCtD
Triflupromazine—ABCB1—Vinblastine—hematologic cancer	0.015	0.0236	CbGbCtD
Triflupromazine—ABCB1—Vincristine—hematologic cancer	0.0148	0.0232	CbGbCtD
Triflupromazine—ABCB1—Cisplatin—hematologic cancer	0.0138	0.0217	CbGbCtD
Triflupromazine—ABCB1—Etoposide—hematologic cancer	0.0135	0.0213	CbGbCtD
Triflupromazine—ABCB1—Dexamethasone—hematologic cancer	0.0111	0.0175	CbGbCtD
Triflupromazine—ABCB1—Doxorubicin—hematologic cancer	0.00923	0.0145	CbGbCtD
Triflupromazine—ABCB1—Methotrexate—hematologic cancer	0.00894	0.0141	CbGbCtD
Triflupromazine—Acepromazine—SLC22A1—hematologic cancer	0.000372	0.116	CrCbGaD
Triflupromazine—Thioproperazine—SLC22A1—hematologic cancer	0.000364	0.114	CrCbGaD
Triflupromazine—Pipotiazine—SLC22A1—hematologic cancer	0.000358	0.112	CrCbGaD
Triflupromazine—Clomipramine—GSTP1—hematologic cancer	0.000306	0.0955	CrCbGaD
Triflupromazine—Desipramine—SLC22A1—hematologic cancer	0.000228	0.0711	CrCbGaD
Triflupromazine—Chlorpromazine—SLC22A1—hematologic cancer	0.000194	0.0606	CrCbGaD
Triflupromazine—Imipramine—SLC22A1—hematologic cancer	0.000193	0.0603	CrCbGaD
Triflupromazine—Diltiazem—ABCB1—hematologic cancer	0.000131	0.041	CrCbGaD
Triflupromazine—Acepromazine—ALB—hematologic cancer	0.000113	0.0354	CrCbGaD
Triflupromazine—Thioproperazine—ALB—hematologic cancer	0.000111	0.0346	CrCbGaD
Triflupromazine—Pipotiazine—ALB—hematologic cancer	0.000109	0.034	CrCbGaD
Triflupromazine—Fluphenazine—ABCB1—hematologic cancer	8.99e-05	0.0281	CrCbGaD
Triflupromazine—Clomipramine—ALB—hematologic cancer	8.62e-05	0.0269	CrCbGaD
Triflupromazine—Clomipramine—ABCB1—hematologic cancer	8.23e-05	0.0257	CrCbGaD
Triflupromazine—Chlorprothixene—ABCB1—hematologic cancer	8.19e-05	0.0256	CrCbGaD
Triflupromazine—Promethazine—ABCB1—hematologic cancer	7.29e-05	0.0228	CrCbGaD
Triflupromazine—Trifluoperazine—ABCB1—hematologic cancer	7.19e-05	0.0225	CrCbGaD
Triflupromazine—Desipramine—ABCB1—hematologic cancer	6.62e-05	0.0207	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—hematologic cancer	5.91e-05	0.0185	CrCbGaD
Triflupromazine—Chlorpromazine—ABCB1—hematologic cancer	5.64e-05	0.0176	CrCbGaD
Triflupromazine—Imipramine—ABCB1—hematologic cancer	5.61e-05	0.0175	CrCbGaD
Triflupromazine—DRD2—Signaling Pathways—TSC2—hematologic cancer	9.61e-06	8.16e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	9.5e-06	8.06e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGF2—hematologic cancer	9.47e-06	8.03e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PIK3CA—hematologic cancer	9.43e-06	8e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TSC2—hematologic cancer	9.41e-06	7.98e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MDM2—hematologic cancer	9.39e-06	7.97e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3R1—hematologic cancer	9.34e-06	7.92e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	9.29e-06	7.88e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGFR3—hematologic cancer	9.25e-06	7.85e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTP1—hematologic cancer	9.21e-06	7.82e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK14—hematologic cancer	9.16e-06	7.77e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CB—hematologic cancer	9.14e-06	7.75e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MTOR—hematologic cancer	9.14e-06	7.75e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—JAK2—hematologic cancer	9.07e-06	7.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	9.05e-06	7.68e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ESR1—hematologic cancer	8.98e-06	7.62e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	8.96e-06	7.6e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	8.94e-06	7.58e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CA—hematologic cancer	8.89e-06	7.54e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FN1—hematologic cancer	8.87e-06	7.53e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MDM2—hematologic cancer	8.86e-06	7.51e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	8.85e-06	7.5e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ESR1—hematologic cancer	8.79e-06	7.46e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BAD—hematologic cancer	8.77e-06	7.44e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	8.77e-06	7.44e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HRAS—hematologic cancer	8.72e-06	7.4e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FN1—hematologic cancer	8.68e-06	7.37e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	8.68e-06	7.37e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	8.68e-06	7.36e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MTOR—hematologic cancer	8.62e-06	7.31e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CB—hematologic cancer	8.62e-06	7.31e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BAD—hematologic cancer	8.58e-06	7.28e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	8.58e-06	7.28e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CDKN1B—hematologic cancer	8.58e-06	7.28e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FN1—hematologic cancer	8.57e-06	7.27e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTEN—hematologic cancer	8.53e-06	7.24e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CD80—hematologic cancer	8.51e-06	7.22e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	8.5e-06	7.21e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	8.49e-06	7.2e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KIT—hematologic cancer	8.49e-06	7.2e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—NRAS—hematologic cancer	8.49e-06	7.2e-05	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—hematologic cancer	8.48e-06	7.2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	8.47e-06	7.19e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BAD—hematologic cancer	8.47e-06	7.19e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTM1—hematologic cancer	8.47e-06	7.18e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NCOR1—hematologic cancer	8.47e-06	7.18e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—hematologic cancer	8.41e-06	7.13e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2—hematologic cancer	8.39e-06	7.12e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	8.39e-06	7.12e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—hematologic cancer	8.35e-06	7.08e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTPN11—hematologic cancer	8.34e-06	7.08e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CD80—hematologic cancer	8.33e-06	7.06e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	8.31e-06	7.05e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KIT—hematologic cancer	8.31e-06	7.05e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	8.31e-06	7.05e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HRAS—hematologic cancer	8.23e-06	6.98e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CD80—hematologic cancer	8.22e-06	6.97e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KIT—hematologic cancer	8.2e-06	6.96e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	8.2e-06	6.96e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	8.2e-06	6.96e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCND1—hematologic cancer	8.18e-06	6.94e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	8.16e-06	6.93e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—JUN—hematologic cancer	8.16e-06	6.93e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—EP300—hematologic cancer	8.14e-06	6.9e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	8.13e-06	6.9e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDKN1B—hematologic cancer	8.09e-06	6.86e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CREB1—hematologic cancer	8.08e-06	6.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	8.06e-06	6.84e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—hematologic cancer	8e-06	6.79e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BRAF—hematologic cancer	7.98e-06	6.77e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	7.96e-06	6.75e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—hematologic cancer	7.93e-06	6.72e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2—hematologic cancer	7.91e-06	6.71e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CDKN1A—hematologic cancer	7.91e-06	6.71e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CREB1—hematologic cancer	7.91e-06	6.71e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL2—hematologic cancer	7.91e-06	6.71e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTEN—hematologic cancer	7.9e-06	6.7e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6R—hematologic cancer	7.88e-06	6.69e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—hematologic cancer	7.88e-06	6.68e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CREBBP—hematologic cancer	7.87e-06	6.68e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	7.86e-06	6.66e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BRAF—hematologic cancer	7.81e-06	6.63e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	7.81e-06	6.62e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL2—hematologic cancer	7.74e-06	6.57e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK8—hematologic cancer	7.72e-06	6.55e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6R—hematologic cancer	7.72e-06	6.55e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCND1—hematologic cancer	7.72e-06	6.55e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	7.71e-06	6.54e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	7.71e-06	6.54e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—hematologic cancer	7.7e-06	6.54e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—JUN—hematologic cancer	7.7e-06	6.53e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	7.64e-06	6.48e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	7.62e-06	6.46e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	7.61e-06	6.45e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EP300—hematologic cancer	7.53e-06	6.39e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	7.51e-06	6.37e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—hematologic cancer	7.48e-06	6.35e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	7.46e-06	6.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDKN1A—hematologic cancer	7.46e-06	6.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTEN—hematologic cancer	7.45e-06	6.32e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	7.39e-06	6.27e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	7.35e-06	6.24e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SRC—hematologic cancer	7.32e-06	6.21e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—KRAS—hematologic cancer	7.31e-06	6.2e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	7.31e-06	6.2e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK8—hematologic cancer	7.29e-06	6.18e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—hematologic cancer	7.27e-06	6.16e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	7.26e-06	6.16e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	7.24e-06	6.14e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	7.21e-06	6.12e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	7.15e-06	6.07e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGF2—hematologic cancer	7.15e-06	6.06e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	7.14e-06	6.06e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—hematologic cancer	7.13e-06	6.05e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EP300—hematologic cancer	7.1e-06	6.02e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—hematologic cancer	7.06e-06	5.99e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	7.06e-06	5.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	7.05e-06	5.98e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NRAS—hematologic cancer	7.05e-06	5.98e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	7e-06	5.93e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SRC—hematologic cancer	6.91e-06	5.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	6.91e-06	5.86e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	6.9e-06	5.85e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—JAK2—hematologic cancer	6.85e-06	5.81e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	6.81e-06	5.78e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK3—hematologic cancer	6.75e-06	5.72e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—hematologic cancer	6.73e-06	5.71e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	6.71e-06	5.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	6.7e-06	5.69e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MDM2—hematologic cancer	6.69e-06	5.67e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—hematologic cancer	6.66e-06	5.65e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NRAS—hematologic cancer	6.64e-06	5.64e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	6.62e-06	5.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	6.57e-06	5.57e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—hematologic cancer	6.56e-06	5.57e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—hematologic cancer	6.55e-06	5.55e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	6.55e-06	5.55e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MTOR—hematologic cancer	6.51e-06	5.52e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	6.51e-06	5.52e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	6.49e-06	5.5e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	6.46e-06	5.48e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	6.37e-06	5.4e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	6.37e-06	5.4e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK3—hematologic cancer	6.36e-06	5.4e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CG—hematologic cancer	6.29e-06	5.33e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	6.29e-06	5.33e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	6.29e-06	5.33e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	6.21e-06	5.27e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—hematologic cancer	6.19e-06	5.25e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—hematologic cancer	6.17e-06	5.24e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	6.11e-06	5.18e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	6.08e-06	5.16e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KRAS—hematologic cancer	6.06e-06	5.14e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	6.04e-06	5.12e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CA—hematologic cancer	6.02e-06	5.11e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	6e-06	5.09e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—hematologic cancer	5.98e-06	5.08e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	5.98e-06	5.07e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2—hematologic cancer	5.98e-06	5.07e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—hematologic cancer	5.95e-06	5.04e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	5.91e-06	5.01e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	5.9e-06	5e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	5.86e-06	4.97e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2—hematologic cancer	5.85e-06	4.96e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	5.84e-06	4.95e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CREBBP—hematologic cancer	5.83e-06	4.94e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCND1—hematologic cancer	5.83e-06	4.94e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	5.82e-06	4.94e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—JUN—hematologic cancer	5.81e-06	4.93e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	5.78e-06	4.9e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2—hematologic cancer	5.77e-06	4.9e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	5.74e-06	4.87e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KRAS—hematologic cancer	5.72e-06	4.85e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	5.7e-06	4.84e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—JUN—hematologic cancer	5.69e-06	4.83e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	5.64e-06	4.78e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	5.63e-06	4.77e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTEN—hematologic cancer	5.62e-06	4.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—JUN—hematologic cancer	5.62e-06	4.76e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	5.57e-06	4.73e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CD—hematologic cancer	5.53e-06	4.69e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	5.52e-06	4.68e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	5.5e-06	4.67e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	5.5e-06	4.67e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	5.49e-06	4.65e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—hematologic cancer	5.46e-06	4.63e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	5.44e-06	4.62e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	5.43e-06	4.61e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—hematologic cancer	5.39e-06	4.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	5.38e-06	4.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	5.37e-06	4.55e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EP300—hematologic cancer	5.36e-06	4.55e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	5.31e-06	4.51e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	5.3e-06	4.5e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	5.25e-06	4.46e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EP300—hematologic cancer	5.25e-06	4.45e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3R1—hematologic cancer	5.22e-06	4.43e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SRC—hematologic cancer	5.21e-06	4.42e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EP300—hematologic cancer	5.18e-06	4.39e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HRAS—hematologic cancer	5.15e-06	4.37e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SRC—hematologic cancer	5.1e-06	4.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—hematologic cancer	5.08e-06	4.31e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	5.08e-06	4.31e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SRC—hematologic cancer	5.04e-06	4.27e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	5.03e-06	4.27e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	5.02e-06	4.26e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	4.97e-06	4.22e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—hematologic cancer	4.93e-06	4.18e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	4.92e-06	4.17e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—hematologic cancer	4.92e-06	4.17e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	4.91e-06	4.16e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	4.91e-06	4.16e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HRAS—hematologic cancer	4.86e-06	4.12e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	4.86e-06	4.12e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	4.85e-06	4.11e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CB—hematologic cancer	4.82e-06	4.09e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	4.8e-06	4.08e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	4.7e-06	3.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—hematologic cancer	4.67e-06	3.96e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	4.66e-06	3.95e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—hematologic cancer	4.65e-06	3.95e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	4.64e-06	3.94e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—hematologic cancer	4.57e-06	3.88e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	4.56e-06	3.87e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—hematologic cancer	4.55e-06	3.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—hematologic cancer	4.51e-06	3.83e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	4.5e-06	3.82e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	4.32e-06	3.66e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—hematologic cancer	4.29e-06	3.64e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	4.23e-06	3.58e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	4.17e-06	3.54e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTEN—hematologic cancer	4.16e-06	3.53e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—EP300—hematologic cancer	3.97e-06	3.37e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	3.97e-06	3.36e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	3.88e-06	3.29e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—hematologic cancer	3.84e-06	3.26e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	3.83e-06	3.25e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—hematologic cancer	3.76e-06	3.19e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—hematologic cancer	3.71e-06	3.14e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	3.67e-06	3.11e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	3.59e-06	3.05e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	3.55e-06	3.01e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—hematologic cancer	3.51e-06	2.98e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—hematologic cancer	3.44e-06	2.92e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—hematologic cancer	3.39e-06	2.88e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	3.24e-06	2.75e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	3.17e-06	2.69e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	3.13e-06	2.66e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.94e-06	2.49e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—hematologic cancer	2.4e-06	2.03e-05	CbGpPWpGaD
